CD8A

CD8A encodes the CD8α chain, a T cell co-receptor whose function in MHC class I-restricted antigen recognition and downstream Lck signaling is governed by its dimerization state, its extracellular ligands, and post-translational and epigenetic regulation (PMID:17506031, PMID:24104458). Co-receptor activity for CD8-dependent TCRs requires the CD8α/β heterodimer; CD8α/α homodimers are insufficient, as gene transfer of a CD8-dependent TCR into CD8β-deficient T cells abolishes antigen-specific cytotoxicity (PMID:17506031). Beyond MHC-I, CD8α engages additional ligands with distinct functional consequences: interaction with PILRα maintains naïve and memory CD8+ T cells in a quiescent state, and loss of this engagement drives spontaneous activation and death without antigen (PMID:35617401), whereas binding to N-domain-glycosylated CEACAM5 on intestinal epithelium activates CD8-associated Lck and confers suppressive function on CD8+ T cells (PMID:24104458). Co-receptor function is dampened by ART2.2-mediated ADP-ribosylation of the CD8β chain, which impairs MHC-I tetramer binding and cytotoxicity (PMID:23575529), while CpG methylation of the Cd8a locus reversibly controls surface CD8 levels during effector T cell polarization (PMID:24675400). The CD8α-Cre lineage has also been used to show that T cell-intrinsic TGFβ/ALK5–Smad2 signaling represses CXCR3 to limit CD8+ T cell trafficking into tumors (PMID:32273499).

1. 2007 High

   Established that co-receptor function for CD8-dependent TCRs is a property of the CD8α/β heterodimer rather than CD8α/α homodimers, defining the structural requirement for productive MHC-I co-recognition.

   Evidence Retroviral TCR gene transfer into CD8β-deficient primary T cells with anti-CD8α/anti-CD8β blocking and cytotoxicity/IFN-γ readouts

   PMID:17506031

   Open questions at the time

   • Does not resolve the structural basis by which the β chain enables co-receptor activity
   • Restricted to a defined CD8-dependent versus CD8-independent TCR pair
2. 2013 High

   Showed that CD8αβ co-receptor function is negatively regulated post-translationally by ADP-ribosylation, revealing an extracellular metabolic checkpoint on cytotoxicity.

   Evidence In vitro/in vivo ART2.2 ADP-ribosylation assays on CD8β arginines with MHC-I tetramer binding, in vivo cytotoxicity, and ART2-deficient controls

   PMID:23575529

   Open questions at the time

   • Physiological contexts where extracellular NAD+ reaches modifying concentrations not defined
   • Effect on TCR signaling kinetics beyond tetramer binding not detailed
3. 2013 Medium

   Identified CEACAM5 as a glycosylation-dependent CD8α ligand on intestinal epithelium that triggers Lck activation and imprints a suppressive program, expanding CD8α's ligand repertoire beyond MHC-I.

   Evidence Co-IP, antibody blocking, CD8α binding affinity with glycosylation mutants, Lck phosphorylation, and in vitro CD4+ suppression assay

   PMID:24104458

   Open questions at the time

   • Single-lab study without in vivo genetic validation
   • Whether suppressive function operates in vivo in the gut not established
4. 2014 High

   Demonstrated that surface CD8 levels are reversibly set by CpG methylation of the Cd8a locus during effector polarization, establishing an epigenetic layer of co-receptor regulation.

   Evidence Bisulfite sequencing of Cd8a CpG sites with type 1/2 polarization, IFN-γ restimulation, adoptive transfer, and flow cytometry

   PMID:24675400

   Open questions at the time

   • Methyltransferases/demethylases acting on the locus not identified
   • Functional consequence of CD8(low) state for TCR signaling not measured
5. 2022 High

   Defined a ligand-driven quiescence function for CD8α, showing that CD8α-PILRα engagement actively restrains antigen-independent activation of naïve and memory CD8+ T cells.

   Evidence Inducible CD8α conditional knockout, PILRα ligand identification, quiescence assays, and adoptive transfer in mice and humans

   PMID:35617401

   Open questions at the time

   • Signaling pathway from CD8α-PILRα that enforces quiescence not delineated
   • Relationship between quiescence role and classical co-receptor role unresolved
6. 2022 High

   Used CD8α-Cre lineage targeting to show T cell-intrinsic TGFβ/ALK5–Smad2 signaling represses CXCR3 and limits CD8+ T cell tumor infiltration.

   Evidence CD8αCre-ALK5flox conditional knockout, Smad2 ChIP at the CXCR3 promoter, CXCL10 migration assays, and in vivo CXCR3 blockade

   PMID:32273499

   Open questions at the time

   • Reports a CD8α-Cre-driven pathway rather than a direct CD8α molecular function
   • Whether CD8α protein itself participates in this signaling not addressed

• How CD8α integrates its competing ligand engagements (MHC-I, PILRα, CEACAM5) and regulatory modifications into a unified signaling decision remains unresolved.
• No structural model reconciling distinct ligand interfaces
• Crosstalk between epigenetic, post-translational, and ligand-based regulation undefined